Skip to content

Donald Hedeker

3 papers in the library · 6 citations · publishing 2017-2026

Papers

Sort Most recent Most cited

m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs.

Psychedelic Medicine March 1, 2026 Jonah Griffin-Stolbach, Hanna Molla, Donald Hedeker et al.

There has been great interest in the use of very low doses of psychedelic drugs like lysergic acid diethylamide (LSD) to improve mood and cognition. However, controlled studies have thus far provided little support for their efficacy. One challenge is that the subjective effects are subtle and on the threshold of detectability, whereas the questionnaires used to assess the drugs' effects were...

Mindfulness-Based Smoking Cessation Delivered Through Telehealth and Text Messaging for Low-Income Smokers: Protocol for a Randomized Controlled Trial

JMIR Research Protocols August 1, 2022 Claire Adams Spears, Josephine Mhende, China Hawkins et al. 6 citations

BACKGROUND: Tobacco use is the leading cause of preventable morbidity and mortality. Adults with low income and members of certain racial and ethnic minority groups are less likely to quit, and therefore, they experience profound tobacco-related health disparities. Mindfulness training can increase the rates of smoking cessation and lapse recovery, and telehealth and SMS text messaging have the...

Mechanisms Underlying Mindfulness-Based Addiction Treatment versus Cognitive Behavioral Therapy and Usual Care for Smoking Cessation

Journal of Consulting and Clinical Psychology June 26, 2017 C. Spears, Donald Hedeker, Liang Li et al.

Objective: To examine cognitive and affective mechanisms underlying mindfulness-based addiction treatment (MBAT) versus cognitive-behavioral therapy (CBT) and usual care (UC) for smoking cessation. Method: Participants in the parent study from which data were drawn (N = 412; 54.9% female; 48.2% African American, 41.5% non-Latino White, 5.4% Latino, 4.9% other; 57.6% annual income <$30,000) were...